Achuyt Bhattarai

Summary

Affiliation: Karolinska Institutet
Country: Sweden

Publications

  1. ncbi Amodiaquine during pregnancy
    Achuyt Bhattarai
    Karolinska Institutet, Stockhlom, Sweden
    Lancet Infect Dis 4:721-2; discussion 722. 2004
  2. ncbi Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar
    Achuyt Bhattarai
    Infectious Diseases Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
    PLoS Med 4:e309. 2007
  3. ncbi Public health impact of drug resistant Plasmodium falciparum malaria
    Anders Bjorkman
    Malaria Research Unit M9 02, Unit of Infectious Diseases, Department of Medicine, Karolinska University Hospital, Solna 17176, Stockholm, Sweden
    Acta Trop 94:163-9. 2005
  4. ncbi Polymorphism of antimalaria drug metabolizing, nuclear receptor, and drug transport genes among malaria patients in Zanzibar, East Africa
    Pedro Eduardo Ferreira
    Malaria Research Laboratory, Unit of Infectious Diseases, Department of Medicine, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden
    Ther Drug Monit 30:10-5. 2008
  5. ncbi Population pharmacokinetics of amodiaquine and desethylamodiaquine in pediatric patients with uncomplicated falciparum malaria
    Sofia Friberg Hietala
    Unit for Pharmacokinetics and Drug Metabolism, Department of Pharmacology, Sahlgrenska Academy at Goteborg University, Box 431, Goteborg 405 30, Sweden
    J Pharmacokinet Pharmacodyn 34:669-86. 2007

Collaborators

Detail Information

Publications5

  1. ncbi Amodiaquine during pregnancy
    Achuyt Bhattarai
    Karolinska Institutet, Stockhlom, Sweden
    Lancet Infect Dis 4:721-2; discussion 722. 2004
  2. ncbi Impact of artemisinin-based combination therapy and insecticide-treated nets on malaria burden in Zanzibar
    Achuyt Bhattarai
    Infectious Diseases Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden
    PLoS Med 4:e309. 2007
    ..We investigated temporal trends in Plasmodium falciparum prevalence and malaria-related health parameters following the implementation of these two malaria control interventions in Zanzibar...
  3. ncbi Public health impact of drug resistant Plasmodium falciparum malaria
    Anders Bjorkman
    Malaria Research Unit M9 02, Unit of Infectious Diseases, Department of Medicine, Karolinska University Hospital, Solna 17176, Stockholm, Sweden
    Acta Trop 94:163-9. 2005
    ..Early switch to artemisinin based combination therapy (ACT) represents such a critical and urgent strategy...
  4. ncbi Polymorphism of antimalaria drug metabolizing, nuclear receptor, and drug transport genes among malaria patients in Zanzibar, East Africa
    Pedro Eduardo Ferreira
    Malaria Research Laboratory, Unit of Infectious Diseases, Department of Medicine, Karolinska University Hospital, Karolinska Institute, Stockholm, Sweden
    Ther Drug Monit 30:10-5. 2008
    ..Ten (10.1%) subjects were predicted to be low metabolizers simultaneously for CYP3A4 and CYP3A5. This fraction of the population is suggested to be under higher exposure to certain antimalarials, including lumefantrine and quinine...
  5. ncbi Population pharmacokinetics of amodiaquine and desethylamodiaquine in pediatric patients with uncomplicated falciparum malaria
    Sofia Friberg Hietala
    Unit for Pharmacokinetics and Drug Metabolism, Department of Pharmacology, Sahlgrenska Academy at Goteborg University, Box 431, Goteborg 405 30, Sweden
    J Pharmacokinet Pharmacodyn 34:669-86. 2007
    ..The age-based dosing schedule currently recommended in Zanzibar appeared to result in inadequate exposure to N-DEAQ in many patients...